Barely Significant
← all excerpts

Optimisation of a primary human CAR-NK cell manufacturing pipeline.

Clin Transl Immunology · 2024 · PMC11063921 · PMID 38707997

1
hedged sentence
closest p
boldest claim

The sentences

a slight trendno p-value reported
Despite a slight trend towards increased transduction efficiency in CB‐ compared to PB‐derived NK cells, on a per cell basis, PB‐derived anti‐CD19 CAR‐NK cells were more potent at killing CD19 + Nalm6 cells after 14 days of culture.

also in 2,235 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.